Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Suzhou Yihe Pharmaceutical

Request full access

Inhalation formulation solutions providing targeted drug delivery systems

ChinaFounded 2020Biotech & Life Sciences

About Suzhou Yihe Pharmaceutical

Suzhou Yihe Pharmaceutical, also known as Inhal Pharma, is a company specializing in the research and development of inhalation formulations, devices, and filling equipment. The company was co-founded in 2020 by Professor Jingxu Zhu, a Fellow of the Royal Society of Canada and the Canadian Academy of Engineering, and Dr. Kaiqi Shi. Professor Zhu's team has been engaged in inhalation drug delivery research since 1994. The company's headquarters, Ningbo Inhal Pharma Co., Ltd., is located in Ningbo and focuses on the development and production of inhalation devices and filling equipment. In 2021, the company established its Suzhou R&D Center, which concentrates on the development of inhalation formulations.

Inhal Pharma aims to provide turnkey solutions in the inhalation drug delivery sector for global pharmaceutical companies. The firm's core technologies include ultrafine powder preparation, precise quantitative repackaging of ultrafine dry powder drugs, and the design and development of low-resistance inhalation flow channels. They develop both carrier-free and carrier-based formulations. The company's product and service offerings cover the design and development of various dry powder inhalers, such as capsule-based, disc-based, blister-based, and reservoir-based types, alongside services like 3D printing and numerical simulation. In October 2023, the company announced the completion of a Series A financing round, raising over 50 million Yuan RMB.

Source: Dealroom company data

Suzhou Yihe Pharmaceutical in its local ecosystem

Live from Dealroom

The Suzhou Yihe Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Saiying Capital
  • Yishang Huicheng
  • Shaanxi Fund
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China66.7%
🇺🇸 United States33.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Suzhou Yihe Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Yihe Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.